Ditchcarbon
  • Customers
  1. Organizations
  2. Maravai LifeSciences
Public Profile
Research Services
US
updated 9 days ago

Maravai LifeSciences

Company website

Maravai LifeSciences, a leading provider in the life sciences sector, is headquartered in the United States and operates across key regions globally. Founded in 2016, the company has rapidly established itself as a pivotal player in the biotechnology industry, focusing on critical areas such as nucleic acid production, protein detection, and cell culture solutions. Maravai's core offerings include high-quality reagents and services that support the development of therapeutics and diagnostics. Their unique approach to custom synthesis and scalable production sets them apart in a competitive market. With a commitment to innovation, Maravai has achieved significant milestones, including strategic acquisitions that enhance their capabilities and market reach. Recognised for their excellence, Maravai LifeSciences continues to drive advancements in life sciences, contributing to the global health landscape.

DitchCarbon Score

How does Maravai LifeSciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Maravai LifeSciences's score of 33 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

64%

Let us know if this data was useful to you

Maravai LifeSciences's reported carbon emissions

In 2024, Maravai LifeSciences reported total carbon emissions of approximately 12,000,000 kg CO2e, comprising Scope 1 emissions of about 862,580 kg CO2e, Scope 2 emissions of approximately 2,208,570 kg CO2e (market-based), and significant Scope 3 emissions of around 10,027,390 kg CO2e from capital goods alone. The previous year, 2023, saw total emissions of about 11,000,000 kg CO2e, with Scope 1 at 736,590 kg CO2e and Scope 2 at approximately 1,993,000 kg CO2e (market-based). Maravai's emissions data reflects a comprehensive approach to carbon accounting, including all three scopes. However, there are currently no specific reduction targets or climate pledges documented, indicating a potential area for future commitment. The company has not inherited emissions data from any parent organisation, ensuring that its reported figures are solely its own. Overall, Maravai LifeSciences is positioned within the industry context of increasing scrutiny on carbon emissions, and while it has made strides in transparency, the absence of formal reduction initiatives suggests an opportunity for enhanced climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
330,000
000,000
000,000
000,000
Scope 2
1,103,000
0,000,000
0,000,000
0,000,000
Scope 3
-
-
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Maravai LifeSciences's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Maravai LifeSciences is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Maravai LifeSciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Enzo Life Sciences Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Nutcracker Therapeutics, Inc.

US
•
Research and development services (73)
Updated 13 days ago

DNA Script SAS

FR
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Azenta Life Science

US
•
Health and social work services (85)
Updated 3 days ago

Telesis Bio, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

Integrated DNA Technologies, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy